|Articles|October 28, 2015

Alison Morris on the Future of Screening for Distress

Alison Morris, Hematology/Oncology Nurse Practitioner, Stanford Health Care, discusses her hopes for the future of screening for emotional and physical distress.

Learn more about a study looking at emotional and physical distress.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

Managing Side Effects for Brain Metastasis in HER2-Positive Breast Cancer

Managing Side Effects for Brain Metastasis in HER2+ Breast Cancer

ByDr. Vikram C. Gorantla

December 22nd 2025

As he faces cancer for the second time since 2024, actor Dave Coulier is incredibly aware of the power of positive thinking.

Dave Coulier Embraces Positivity Amid a Second Cancer Diagnosis

ByDave Coulier

December 19th 2025

An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects.

IL-18-armored CAR T Drives Remissions in Relapsed B-Cell Leukemia

ByDr. Matthew P. Connor

December 19th 2025

CURE spoke with a clinical psychologist about the stigmas often faced by patients with lung cancer.

Patients With Lung Cancer Face Smoking-Related Stigma

ByPatricia I. Moreno

December 19th 2025

Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path

BySpencer Feldman

December 18th 2025

Alison Morris on the Future of Screening for Distress

Newsletter

Related Content

Managing Side Effects for Brain Metastasis in HER2+ Breast Cancer

Dave Coulier Embraces Positivity Amid a Second Cancer Diagnosis

IL-18-armored CAR T Drives Remissions in Relapsed B-Cell Leukemia

Patients With Lung Cancer Face Smoking-Related Stigma

Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path

Trending on CURE

What No One Tells You About Life After Breast Cancer: Fighting for Care

FDA Green Lights 'One-Minute' Injection for R/R Follicular Lymphoma Treatment

Dave Coulier Embraces Positivity Amid a Second Cancer Diagnosis

Managing Side Effects for Brain Metastasis in HER2+ Breast Cancer

How Modern Research Is Transforming Metastatic HER2+ Breast Cancer Care